Novel Conditionally Active Bispecific EpCAM x CD3 T Cell Engagers Targeting Solid Tumors

February 2, 2023

Novel Conditionally Active Bispecific T Cell Engagers Targeting Solid Tumors

February 2, 2023

Novel conditionally active biologic (CAB) antibodies

February 2, 2023